Efficacy and Quality of Antibacterial Generic Products Approved for Human Use: A Systematic Review

Bioequivalence Requirements in the European Union: Critical Discussion

(2012) Alfredo García-Arieta et al.   AAPS Journal

Quality Assessment of U.S. Marketplace Vancomycin for Injection Products Using High-Resolution Liquid Chromatography-Mass Spectrometry and Potency Assays

(2012) Michael E. Hadwiger et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Product Quality of Parenteral Vancomycin Products in the United States

(2012) S. Nambiar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Therapeutic Equivalence Requires Pharmaceutical, Pharmacokinetic, and Pharmacodynamic Identities: True Bioequivalence of a Generic Product of Intravenous Metronidazole

(2012) M. Agudelo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic Properties and Bioequivalence of Two Sulfadoxine/Pyrimethamine Fixed-Dose Combination Tablets: A Parallel-Design Study in Healthy Chinese Male Volunteers

(2012) Yan-Mei Liu et al.   CLINICAL THERAPEUTICS

Generic antibiotic drugs: Is effectiveness guaranteed?

(2012) R. Gauzit et al.   MEDECINE ET MALADIES INFECTIEUSES

Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model

(2011) Carlos A. Rodriguez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Equal efficacy of a generic piperacillin/tazobactam formulation: results of a local screening protocol

(2011) Sarah Tschudin Sutter et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Economic incentives for the (over-)prescription of broad-spectrum antimicrobials in German ambulatory care

(2011) Klaus Kaier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator

(2010) O. Vesga et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin

(2010) Carlos A Rodriguez et al.   BMC INFECTIOUS DISEASES

Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/ probenecid (333 mg): A randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers

(2010) Huizhe Wu et al.   CLINICAL THERAPEUTICS

Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance

(2010) U. S. Jensen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus

(2010) Shigeru Fujimura et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model

(2010) Andres F. Zuluaga et al.   PLoS One

Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers

(2009) Mario Del Tacca et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Generic versus Non-Generic Formulation of Extended-Release Clarithromycin in Patients with Community-Acquired Respiratory Tract Infections

(2009) J.R. Snyman et al.   CLINICAL DRUG INVESTIGATION

Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots

(2009) Gary J. Moet et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia

(2009) Carlos A. Rodriguez et al.   JOURNAL OF INFECTION

In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn®, Wyeth) formulation

(2008) Ronald N. Jones et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Study of the acceptability of antibiotic syrups, suspensions, and oral solutions prescribed to pediatric outpatients

(2008) Robert Cohen et al.   EUROPEAN JOURNAL OF PEDIATRICS

In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin

(2008) Shigeru Fujimura et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease

(2008) Aaron S. Kesselheim   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Generic substitution in the treatment of epilepsy: Case evidence of breakthrough seizures

(2008) M. J. Berg et al.   NEUROLOGY

The role of virulence determinants in community-associated MRSA pathogenesis

(2008) Binh An Diep et al.   TRENDS IN MICROBIOLOGY

Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime

(2007) Ekaterini Mastoraki et al.   JOURNAL OF INFECTION